United States · Series B startup

Who invested in Cadent Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$40Mraised across 1 round since 2018, from 1 source

Latest round
Series B, $40MNov 2018
Investors
5
See who backed them

The rounds

  1. Nov 2018
    Series B$40M

    Reported by FinSMEs

Everyone who backed them

Access IndustriesCorporate VC1round
Cowen GroupGrowth equity1round
Atlas Venture/ Qimingno record of our own yet1round
Clal Biotechnology Industriesno record of our own yet1round
Novartis Institutes for Biomedical Researchno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cadent Therapeutics

Who invested in Cadent Therapeutics?

Cadent Therapeutics's investors include Access Industries, Cowen Group, Atlas Venture/ Qiming, Clal Biotechnology Industries and Novartis Institutes for Biomedical Research.

How much has Cadent Therapeutics raised?

Cadent Therapeutics has raised $40M across 1 round since 2018.

When did Cadent Therapeutics last raise?

Cadent Therapeutics's most recent round was a Series B of $40M in Nov 2018.

What was Cadent Therapeutics's biggest round?

Its most recent round, $40M in Nov 2018, is also its largest on record.

Who backed Cadent Therapeutics first?

Cadent Therapeutics's first round on record, in Nov 2018, was backed by Access Industries, Cowen Group and Atlas Venture/ Qiming and 2 others.

What stage is Cadent Therapeutics at?

Cadent Therapeutics's latest named round is a Series B, in Nov 2018.

Where is Cadent Therapeutics based?

Cadent Therapeutics is based in the United States.

Companies like Cadent Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.